Abiopharma

Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™

Travere Therapeutics Provides Corporate Update and 2026 Outlook

New Form 3 - Certara, Inc. Filed: 2026-01-12 AccNo: 0002104700-26-000003 Size: 6 KB

(99% Neutral) Elevai Labs (ELAB) Announces Business Combination

New Form S-8 POS - iRhythm Holdings, Inc. Filed: 2026-01-12 AccNo: 0001104659-26-002907 Size: 85 KB

📋 William Lewis (Officer) plans to sell 19K shares of INSMED INC (at $169.00 each, total $3.2M) Filed: Jan 12, 2026 | ID: 001868

Hui Yvonne 🔴 sold 372 shares of Phreesia, Inc. (PHR) at $17.47 Transaction Date: Jan 08, 2026 | Filing ID: 000014

New Form 3 - Oncology Institute, Inc. Filed: 2026-01-12 AccNo: 0001079973-26-000073 Size: 10 KB

New Form S-8 POS - iRhythm Holdings, Inc. Filed: 2026-01-12 AccNo: 0001104659-26-002906 Size: 85 KB

New Form S-8 POS - iRhythm Holdings, Inc. Filed: 2026-01-12 AccNo: 0001104659-26-002905 Size: 86 KB

Hoffman Allison C 🔴 sold 6.6K shares of Phreesia, Inc. (PHR) at $17.01 Transaction Date: Jan 08, 2026 | Filing ID: 000013

Amneal Pharmaceuticals, Inc. - Amneal Unveils Bold New Brand to Reimagine What’s Possible in Making Medicine Accessible for All

New Form S-8 POS - iRhythm Holdings, Inc. Filed: 2026-01-12 AccNo: 0001104659-26-002904 Size: 86 KB

(30% Negative) Apellis Pharmaceuticals Inc (APLS) Announces Delay in initiated Trials for EMPAVELI in two additional nephrology indications Due to Regulatory Process, Safety Review

Gandhi Balaji 🔴 sold 8.0K shares of Phreesia, Inc. (PHR) at $17.01 Transaction Date: Jan 08, 2026 | Filing ID: 000012